SCHEMBL7385295

SCHEMBL7385295

CC(=O)N(c1ccc(NC(=O)Nc2ccccc2C)cc1)C1CCN(CCC(=O)O)C1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
RAB9A P51151 2/20 0.50
NPC1 O15118 1/20 0.50
ITGB1 P05556 11/20 0.44
ITGA4 P13612 11/20 0.44
CHRM2 P08172 1/20 0.43
CHRM3 P20309 1/20 0.43
OPRM1 P35372 1/20 0.43
MEN1 O00255 2/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
DDX3X O00571 1/20 0.42
ITGB3 P05106 1/20 0.41
ITGAV P06756 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7481020 0.91 RAB9A (0.52) KMT2ASMN1; SMN2RAB9ANPC1ITGB1
SCHEMBL7391216 0.87 ITGB1 (0.45) KMT2AITGB1ITGA4OPRM1MEN1
SCHEMBL7485087 0.82 ITGB1 (0.44) KMT2ASMN1; SMN2RAB9ANPC1ITGB1
SCHEMBL7424847 0.81 ITGB1 (0.46) KMT2AITGB1ITGA4OPRM1MEN1
SCHEMBL7390416 0.78 ITGA4 (0.52) KMT2ASMN1; SMN2ITGB1ITGA4CHRM2
SCHEMBL7387024 0.74 ITGB1 (0.46) KMT2ASMN1; SMN2ITGB1ITGA4MEN1
SCHEMBL7391866 0.74 ITGA4 (0.45) KMT2AITGB1ITGA4MEN1MAPT
SCHEMBL7429192 0.74 ITGB1 (0.53) KMT2ASMN1; SMN2RAB9ANPC1ITGB1
SCHEMBL7428617 0.73 OPRM1 (0.49) ITGB1ITGA4CHRM3OPRM1
SCHEMBL7430185 0.71 ITGB1 (0.45) KMT2AITGB1ITGA4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999054321-A1 SUBSTITUTED DIAMINES AND THEIR USE AS CELL ADHESION INHIBITORS AVENTIS PHARMA LIMITED (GB) 1999-10-28 WO disclosed